Royal London updates critical illness cover

Royal London has announced a number of enhancements to its critical illness cover.

Related topics:  Protection
Rozi Jones
3rd October 2016
Kennedy, Head of Protection, Royal London
"Cancer was the top reason for critical illness claims last year and by covering over 60 early stage cancers Royal London is demonstrating its commitment to paying more claims"

The main change is to cancer cover - over 60 early stage cancers are now covered under nine definitions.

Royal London says the changes provide clarity for advisers and customers by removing a long list of specified cancers.

The additional cover definitions will pay a partial payment of the lower of 25% of cover or £25,000 for arcinoma in-situ (other), skin cancer, coronary angioplasty, and central retinal artery or vein occlusion which results in permanent visual loss.

The survival period for CIC and children’s CIC has also been reduced from 14 days to 10 days.

In addition, some definitions have been updated or added. A new Parkinson definition now includes Parkinson plus syndromes that incorporates multiple system atrophy and progressive supranuclear palsy.

Motor neurone disease definition has also been updated to include Kennedy’s disease, which makes the definition ABI+.

Debbie Kennedy, Head of Protection at Royal London, said: “Medical advances mean that cancer is often being diagnosed and treated earlier. Therefore more people require support at the early stages following a cancer diagnosis. We’ve enhanced our critical illness cover to provide financial support and our Helping Hand provides emotional support whenever the customer needs extra help. Cancer was the top reason for critical illness claims last year and by covering over 60 early stage cancers Royal London is demonstrating its commitment to paying more claims and including conditions that matter and really do add value for our customers.”

More like this
CLOSE
Subscribe
to our newsletter

Join a community of over 30,000 intermediaries and keep up-to-date with industry news and upcoming events via our newsletter.